Company
Tango Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an approach that starts and ends with patients, we’re expanding the reach of genetically targeted therapies.
Loading relationship preview